212 related articles for article (PubMed ID: 17872492)
1. Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis.
Konstan MW; Schluchter MD; Xue W; Davis PB
Am J Respir Crit Care Med; 2007 Dec; 176(11):1084-9. PubMed ID: 17872492
[TBL] [Abstract][Full Text] [Related]
2. Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.
Konstan MW; VanDevanter DR; Sawicki GS; Pasta DJ; Foreman AJ; Neiman EA; Morgan WJ
Ann Am Thorac Soc; 2018 Apr; 15(4):485-493. PubMed ID: 29313709
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen therapy for cystic fibrosis lung disease: revisited.
Konstan MW
Curr Opin Pulm Med; 2008 Nov; 14(6):567-73. PubMed ID: 18812834
[TBL] [Abstract][Full Text] [Related]
4. Effect of high-dose ibuprofen in patients with cystic fibrosis.
Konstan MW; Byard PJ; Hoppel CL; Davis PB
N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
[TBL] [Abstract][Full Text] [Related]
5. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
[TBL] [Abstract][Full Text] [Related]
6. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
Ren CL; Pasta DJ; Rasouliyan L; Wagener JS; Konstan MW; Morgan WJ;
J Pediatr; 2008 Dec; 153(6):746-51. PubMed ID: 18760805
[TBL] [Abstract][Full Text] [Related]
7. High-dose ibuprofen therapy associated with esophageal ulceration after pneumonectomy in a patient with cystic fibrosis: a case report.
Mackey JE; Anbar RD
BMC Pediatr; 2004 Sep; 4():19. PubMed ID: 15363106
[TBL] [Abstract][Full Text] [Related]
8. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.
Lands LC; Milner R; Cantin AM; Manson D; Corey M
J Pediatr; 2007 Sep; 151(3):249-54. PubMed ID: 17719932
[TBL] [Abstract][Full Text] [Related]
9. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis.
Konstan MW; Wagener JS; Pasta DJ; Millar SJ; Jacobs JR; Yegin A; Morgan WJ;
Pediatr Pulmonol; 2011 Jun; 46(6):545-53. PubMed ID: 21438174
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry.
Miller MR; Sokol RJ; Narkewicz MR; Sontag MK
Liver Transpl; 2012 May; 18(5):585-93. PubMed ID: 22271602
[TBL] [Abstract][Full Text] [Related]
13. Pyloric channel stricture secondary to high-dose ibuprofen therapy in a patient with cystic fibrosis.
Bell EA; Grothe R; Zivkovich V; Foote JM; Wellendorf J
Ann Pharmacother; 1999 Jun; 33(6):693-6. PubMed ID: 10410182
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.
Zemel BS; Jawad AF; FitzSimmons S; Stallings VA
J Pediatr; 2000 Sep; 137(3):374-80. PubMed ID: 10969263
[TBL] [Abstract][Full Text] [Related]
15. Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
Sermet-Gaudelus I; Stoven V; Annereau JP; Witko-Sarsat V; Reinert P; Guyot M; Descamps-Latscha B; Lallemand JY; Lenoir G
Mediators Inflamm; 1999; 8(1):13-5. PubMed ID: 10704084
[TBL] [Abstract][Full Text] [Related]
16. Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?
Vilozni D; Lavie M; Sarouk I; Efrati O
Am J Respir Crit Care Med; 2012 Jul; 186(1):82-7. PubMed ID: 22538801
[TBL] [Abstract][Full Text] [Related]
17. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
18. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
[TBL] [Abstract][Full Text] [Related]
19. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
